Femoroacetabular impingement (FAI) is commonly
associated with early hip arthritis. We reviewed our series of 1300
hip resurfacing procedures. More than 90% of our male patients,
with an average age of 53 years, had cam impingement lesions. In
this condition, there are anterior femoral neck osteophytes, and
a retroverted femoral head on a normally anteverted neck. It is
postulated that FAI results in collision of the anterior neck of
the femur against the rim of the acetabulum, causing damage to the
acetabular labrum and articular cartilage, resulting in osteoarthritis.
Early treatment of FAI involves arthroscopic or open removal of
bone from the anterior femoral neck, as well as repair or removal
of labral tears. However, once osteoarthritis has developed, hip
replacement or hip resurfacing is indicated. Hip resurfacing can
re-orient the head and re-shape the neck. This helps to restore
normal biomechanics to the hip, eliminate FAI, and improve range
of motion. Since many younger men with hip arthritis have FAI, and
are also considered the best candidates for hip resurfacing, it
is evident that resurfacing has a role in these patients.
The management of failed autologous chondrocyte
implantation (ACI) and matrix-assisted autologous chondrocyte implantation
(MACI) for the treatment of symptomatic osteochondral defects in
the knee represents a major challenge. Patients are young, active
and usually unsuitable for prosthetic replacement. This study reports
the results in patients who underwent revision cartilage transplantation
of their original ACI/MACI graft for clinical or graft-related failure.
We assessed 22 patients (12 men and 10 women) with a mean age of
37.4 years (18 to 48) at a mean of 5.4 years (1.3 to 10.9). The
mean period between primary and revision grafting was 46.1 months
(7 to 89). The mean defect size was 446.6 mm2 (150 to
875) and they were located on 11 medial and two lateral femoral condyles,
eight patellae and one trochlea. The mean modified Cincinnati knee score improved from 40.5 (16
to 77) pre-operatively to 64.9 (8 to 94) at their most recent review
(p <
0.001). The visual analogue pain score improved from 6.1
(3 to 9) to 4.7 (0 to 10) (p = 0.042). A total of 14 patients (63%)
reported an ‘excellent’ (n = 6) or ‘good’ (n = 8) clinical outcome,
5 ‘fair’ and one ‘poor’ outcome. Two patients underwent patellofemoral
joint replacement. This study demonstrates that revision cartilage
transplantation after primary ACI and MACI can yield acceptable
functional results and continue to preserve the joint. Cite this article:
This study reports the clinical and sonographic
outcome of arthroscopic rotator cuff repair in patients aged ≥ 70 years
and aimed to determine factors associated with re-tear. A total
of 69 consecutive repairs were performed in 68 patients with a mean
age of 77 years (70 to 86). Constant-Murley scores were collected
pre-operatively and at one year post-operatively. The integrity
of the repair was assessed using ultrasound. Re-tear was detected
in 20 of 62 patients (32%) assessed with ultrasound. Age at operation We conclude that arthroscopic rotator cuff repair in patients
aged ≥ 70 years is a successful procedure. The gender and age of
the patient are important factors to consider when planning management. Cite this article:
Hypermobility is an acknowledged risk factor
for patellar instability. In this case control study the influence
of hypermobility on clinical outcome following medial patellofemoral
ligament (MPFL) reconstruction for patellar instability was studied. A total of 25 patients with hypermobility as determined by the
Beighton criteria were assessed and compared with a control group
of 50 patients who were matched for age, gender, indication for
surgery and degree of trochlear dysplasia. The patients with hypermobility
had a Beighton Score of ≥ 6; the control patients had a score of <
4. All patients underwent MPFL reconstruction performed using semitendinosus
autograft and a standardised arthroscopically controlled technique.
The mean age of the patients was 25 years (17 to 49) and the mean
follow-up was 15 months (6 to 30). Patients with hypermobility had a significant improvement in
function following surgery, with reasonable rates of satisfaction,
perceived improvement, willingness to repeat and likelihood of recommendation.
Functional improvements were significantly less than in control
patients (p <
0.01). Joint hypermobility is not a contraindication to MPFL reconstruction
although caution is recommended in managing the expectations of
patients with hypermobility before consideration of surgery.
We reviewed the long-term clinical and radiological
results of 63 uncemented Low Contact Stress (LCS) total knee replacements
(TKRs) in 47 patients with rheumatoid arthritis. The mean age of
the patients at the time of surgery was 69 years (53 to 81). At
a mean follow-up of 22 years (20 to 25), 12 patients were alive
(17 TKRs), 27 had died (36 TKRs), and eight (ten TKRs) were lost
to follow-up. Revision was necessary in seven patients (seven TKRs, 11.1%)
at a mean of 12.1 years (0 to 19) after surgery. In the surviving
ten patients who had not undergone revision (15 TKRs), the mean
Oxford knee score was 30.2 (16 to 41) at a mean follow-up of 19.5
years (15 to 24.7) and mean active flexion was 105° (90° to 150°).
The survival rate was 88.9% at 20 years (56 of 63) and the Kaplan–Meier
survival estimate, without revision, was 80.2% (95% confidence interval
37 to 100) at 25 years. Cite this article:
Osteochondral lesions (OCLs) occur in up to 70%
of sprains and fractures involving the ankle. Atraumatic aetiologies have
also been described. Techniques such as microfracture, and replacement
strategies such as autologous osteochondral transplantation, or
autologous chondrocyte implantation are the major forms of surgical
treatment. Current literature suggests that microfracture is indicated
for lesions up to 15 mm in diameter, with replacement strategies
indicated for larger or cystic lesions. Short- and medium-term results
have been reported, where concerns over potential deterioration
of fibrocartilage leads to a need for long-term evaluation. Biological augmentation may also be used in the treatment of
OCLs, as they potentially enhance the biological environment for
a natural healing response. Further research is required to establish
the critical size of defect, beyond which replacement strategies
should be used, as well as the most appropriate use of biological augmentation.
This paper reviews the current evidence for surgical management
and use of biological adjuncts for treatment of osteochondral lesions
of the talus. Cite this article:
Total knee replacement (TKR) is one of the most
common operations in orthopaedic surgery worldwide. Despite its
scientific reputation as mainly successful, only 81% to 89% of patients
are satisfied with the final result. Our understanding of this discordance
between patient and surgeon satisfaction is limited. In our experience,
focus on five major factors can improve patient satisfaction rates:
correct patient selection, setting of appropriate expectations,
avoiding preventable complications, knowledge of the finer points
of the operation, and the use of both pre- and post-operative pathways.
Awareness of the existence, as well as the identification of predictors
of patient–surgeon discordance should potentially help with enhancing
patient outcomes. Cite this article:
Treatment of an infected total elbow replacement
(TER) is often successful in eradicating or suppressing the infection.
However, the extensor mechanism may be compromised by both the infection
and the surgery. The goal of this study was to assess triceps function
in patients treated for deep infection complicating a TER. Between
1976 and 2007 a total of 217 TERs in 207 patients were treated for
infection of a TER at our institution. Superficial infections and
those that underwent resection arthroplasty were excluded, leaving
93 TERs. Triceps function was assessed by examination and a questionnaire.
Outcome was measured using the Mayo Elbow Performance Score (MEPS). Triceps weakness was identified in 51 TERs (49 patients, 55%).
At a mean follow-up of five years (0.8 to 34), the extensor mechanism
was intact in 13 patients, with the remaining 38 having bone or
soft-tissue loss. The mean MEPS was 70 points (5 to 100), with a
mean functional score of 18 (0 to 25) of a possible 25 points. Infection following TER can often be eradicated; however, triceps
weakness occurs in more than half of the patients and may represent
a major functional problem. Cite this article:
The December 2013 Shoulder &
Elbow Roundup360 looks at: Platelet-rich plasma; Arthroscopic treatment of sternoclavicular joint osteoarthritis; Synchronous arthrolysis and cuff repair; Arthroscopic arthrolysis; Regional blockade in the beach chair; Recurrent instability; Avoiding iatrogenic nerve injury in elbow arthroscopy; and Complex reconstruction of total elbow revisions
To investigate the differences of open reduction and internal
fixation (ORIF) of complex AO Type C distal radius fractures between
two different models of a single implant type. A total of 136 patients who received either a 2.4 mm (n = 61)
or 3.5 mm (n = 75) distal radius locking compression plate (LCP
DR) using a volar approach were followed over two years. The main
outcome measurements included motion, grip strength, pain, and the
scores of Gartland and Werley, the Short-Form 36 (SF-36) and the
Disabilities of the Arm, Shoulder, and Hand (DASH). Differences
between the treatment groups were evaluated using regression analysis
and the likelihood ratio test with significance based on the Bonferroni
corrected p-value of <
0.003.Objectives
Methods
Two-stage exchange remains the gold standard
for treatment of peri-prosthetic joint infection after total hip replacement
(THR). In the first stage, all components and associated cement
if present are removed, an aggressive debridement is undertaken
including a complete synovectomy, and an antibiotic-loaded cement
spacer is put in place. Patients are then treated with six weeks
of parenteral antibiotics, followed by an ‘antibiotic free period’
to help ensure the infection has been eradicated. If the clinical
evaluation and serum inflammatory markers suggest the infection
has resolved, then the second stage can be completed, which involves
removal of the cement spacer, repeat debridement, and placement
of a new THR. Cite this article:
The December 2013 Hip &
Pelvis Roundup360 looks at: Enhanced recovery works; Acetabular placement; Exercise better than rest in osteoarthritis patients; if Birmingham hip resurfacing is immune from pseudotumour; HIV and arthroplasty; Labral tears revisited; Prophylactic surgery for FAI; and Ceramics and impaction grafting
Tapered, fluted, modular, titanium stems are
increasingly popular in the operative management of Vancouver B2 and
selected B3 peri-prosthetic femoral fractures. We have reviewed
the results at our institution looking at stem survival and clinical
outcomes and compared this with reported outcomes in the literature.
Stem survival at a mean of 54 months was 96% in our series and 97%
for combined published cases. Review of radiology showed maintenance
or improvement of bone stock in 89% of cases with high rates of
femoral union. Favourable clinical outcome scores have reported
by several authors. No difference in survival or clinical scores
was observed between B2 and B3 fractures. Tapered stems are a useful
option in revision for femoral fracture across the spectrum of femoral
bone deficiency. Cite this article:
The October 2012 Wrist &
Hand Roundup360 looks at: osteoarticular flaps to the PIPJ; prognosis after wrist arthroscopy; adipofascial flaps and post-traumatic adhesions; the torn TFCC alone; ulna-shortening osteotomy for ulnar impaction syndrome; Dupuytren’s disease; when a wrist sprain is not a sprain; and shrinking the torn intercarpal ligament.
Conventional uncemented femoral implants provide
dependable long-term fixation in patients with a wide range of functional
requirements. Yet challenges associated with proximal–distal femoral
dimensional mismatch, preservation of bone stock, and minimally
invasive approaches have led to exploration into alternative implant designs.
Short stem designs focusing on a stable metaphyseal fit have emerged
to address these issues in total hip replacement (THR). Uncemented
metaphyseal-engaging short stem implants are stable and are associated
with proximal bone remodeling closer to the metaphysis when compared
with conventional stems and they also have comparable clinical performances.
Short stem metaphyseal-engaging implants can meet the goals of a
successful THR, including tolerating a high level of patient function,
as well as durable fixation. Cite this article:
The February 2014 Research Roundup360 looks at: blood supply to the femoral head after dislocation; diabetes and hip replacement; bone remodelling over two decades following hip replacement; sham surgery as good as arthroscopic meniscectomy; distraction in knee osteoarthritis; whether joint replacement prevent cardiac events; tranexamic acid and knee replacement haemostasis; cartilage colonisation in bipolar ankle grafts; CTs and proof of fusion; atorvastatin for muscle re-innervation after sciatic nerve transection; microfracture and short-term pain in cuff repair; promising early results from L-PRF augmented cuff repairs; and fatty degeneration in a rodent model.
Patients with transfemoral amputation (TFA) often
experience problems related to the use of socket-suspended prostheses.
The clinical development of osseointegrated percutaneous prostheses
for patients with a TFA started in 1990, based on the long-term
successful results of osseointegrated dental implants. Between1999 and 2007, 51 patients with 55 TFAs were consecutively
enrolled in a prospective, single-centre non-randomised study and
followed for two years. The indication for amputation was trauma
in 33 patients (65%) and tumour in 12 (24%). A two-stage surgical
procedure was used to introduce a percutaneous implant to which
an external amputation prosthesis was attached. The assessment of
outcome included the use of two self-report questionnaires, the
Questionnaire for Persons with a Transfemoral Amputation (Q-TFA)
and the Short-Form (SF)-36. The cumulative survival at two years’ follow-up was 92%. The
Q-TFA showed improved prosthetic use, mobility, global situation
and fewer problems (all p <
0.001). The physical function SF-36
scores were also improved (p <
0.001). Superficial infection
was the most frequent complication, occurring 41 times in 28 patients
(rate of infection 54.9%). Most were treated effectively with oral
antibiotics. The implant was removed in four patients because of loosening
(three aseptic, one infection). Osseointegrated percutaneous implants constitute a novel form
of treatment for patients with TFA. The high cumulative survival
rate at two years (92%) combined with enhanced prosthetic use and
mobility, fewer problems and improved quality of life, supports
the ‘revolutionary change’ that patients with TFA have reported
following treatment with osseointegrated percutaneous prostheses. Cite this article:
Several factors have been implicated in unsatisfactory
results after total hip replacement (THR). We examined whether femoral
offset, as measured on digitised post-operative radiographs, was
associated with pain after THR. The routine post-operative radiographs
of 362 patients (230 women and 132 men, mean age 70.0 years (35.2
to 90.5)) who received primary unilateral THRs of varying designs
were measured after calibration. The femoral offset was calculated
using the known dimensions of the implants to control for femoral
rotation. Femoral offset was categorised into three groups: normal
offset (within 5 mm of the height-adjusted femoral offset), low
offset and high offset. We determined the associations to the absolute
final score and the improvement in the mean Western Ontario and
McMaster Universities osteoarthritis index (WOMAC) pain subscale
scores at three, six, 12 and 24 months, adjusting for confounding
variables. The amount of femoral offset was associated with the mean WOMAC
pain subscale score at all points of follow-up, with the low-offset
group reporting less WOMAC pain than the normal or high-offset groups
(six months: 7.01 ( Cite this article: